Pelvic Floor Therapy

Early exercise literature

PubMed lists a 1948 article by A. H. Kegel, titled Progressive resistance exercise in the functional restoration of the perineal muscles, in the American Journal of Obstetrics and Gynecology (volume 56, issue 2, pages 238-48). The record carries no abstract, so only its bibliographic details were verified for this draft.

The sources reviewed do not establish how much of current practice derives from that paper, what its methods were, or how pelvic floor care became a distinct area within physical therapy. Accounts of earlier traditions of pelvic exercise in any region would need scholarly historical sources that this draft does not include.

Systematic reviews and consensus terminology

The Cochrane review of pelvic floor muscle training for urinary incontinence in women was first published in 2001. A 2014 version included 21 trials with 1,281 women, and the 2018 update included 31 trials with 1,817 women from 14 countries. The growth of this trial base is the clearest dated record of how the practice came to be studied systematically.

In December 2016 two international bodies, the International Urogynecological Association (IUGA) and the International Continence Society (ICS), published a joint terminology report on conservative management of female pelvic floor dysfunction. It used nine rounds of internal and external review and defined over 200 terms by consensus.

Terms in the research literature

The sources reviewed use several labels for related activities. The Cochrane reviews and an International Urogynecology Consultation chapter use pelvic floor muscle training (PFMT), a systematic review of treatments after prostate surgery uses pelvic floor muscle therapy, and a U.S. trial network used myofascial physical therapy for pelvic floor tenderness.

The phrase pelvic floor therapy is not defined in these sources and is used here as a family label, not as a single standardized intervention. The IUGA and ICS report defines terms for female pelvic floor dysfunction only, and no equivalent consensus report for men was among the sources reviewed.

Direct, indirect and coordinated training

A 2024 Cochrane review defined direct PFMT as repeated, isolated, voluntary pelvic floor muscle contractions. It described coordinated training as body movements with a concurrent pelvic floor contraction, and indirect training as exercises that are not contractions of the pelvic floor muscles.

Because trials differ in contraction type, supervision and devices, a result from one version of training should not be carried over to another version without checking how each was delivered.

Assessment and supervised programs

The NHS states that a specialist assesses whether a person can contract the pelvic floor muscles and by how much, then designs a program. It describes a program as a minimum of 8 contractions at least 3 times a day lasting at least 3 months, with exercises continuing if they keep helping. These are NHS descriptions of general programs and not individual advice.

The NHS says a GP can refer a person to a local continence service, and in some cases a person can refer themselves. Continence services are staffed by specialist nurses and specialist physiotherapists. For prolapse, the NHS says treatment usually involves a specialist women's health physiotherapist.

Delivery formats in trials

A 2024 Cochrane review of 63 trials compared ways of delivering PFMT: supervised in clinic or at home, individually or in a group, and with e-health tools such as mobile app communication with clinicians. Participants were mostly parous women aged 45 to 65 with stress or stress-predominant mixed incontinence. Some trial arms used an intravaginal or intrarectal training device.

Manual and device-assisted methods

The NHS says electrical stimulation may be suggested if a person cannot contract the muscles, and lists biofeedback and vaginal cones as other options, noting limited evidence of significant benefit for biofeedback.

In trials of myofascial physical therapy for women with bladder pain syndrome and pelvic floor tenderness, up to 10 scheduled treatments were compared with global therapeutic massage across 11 centers. A 2024 trial in China compared radiofrequency therapy with myofascial manual therapy in 176 participants.

Urinary incontinence and prolapse

The Cochrane review authors describe PFMT as the most commonly used physical therapy for women with stress urinary incontinence, sometimes also recommended for mixed incontinence and less commonly for urgency incontinence. An International Urogynecology Consultation chapter describes PFMT in the prevention and treatment of pelvic organ prolapse.

Pregnancy, postpartum and after prostate surgery

A Cochrane review states that PFMT is commonly recommended during pregnancy and after birth to prevent and treat urinary and faecal incontinence. Authors of a 2026 review describe postpartum pelvic floor dysfunction as reduced muscle strength, stress incontinence, prolapse and impaired sexual function.

A 2022 systematic review of treatments for men with incontinence after prostatectomy includes pelvic floor muscle therapy among the options and notes that guidance suggests corrective surgery for men who remain incontinent after trying it.

Pelvic pain

Myofascial approaches have been studied in chronic prostatitis or chronic pelvic pain syndrome, interstitial cystitis or painful bladder syndrome, and myofascial pelvic pain, described as sensitive trigger points in the pelvic floor muscles. These are conditions for which the practice has been studied, not a list of reasons any person should seek it.

Urinary incontinence in women

The 2018 Cochrane review compared PFMT with no treatment or inactive control in 31 trials of 1,817 women. Among women with stress incontinence, 56% in PFMT groups reported their symptoms had resolved versus 6% in controls (risk ratio 8.38, 95% CI 3.68 to 19.07; 4 trials, 165 women; high-quality evidence). Leakage episodes in 24 hours fell by about one (7 trials, 432 women; moderate quality).

A 2024 Cochrane review of 63 trials compared training approaches. Direct PFMT may moderately improve quality of life compared with indirect training (4 trials, 170 women; low certainty), and individual versus group supervision probably makes little to no difference (moderate certainty). Many comparisons were low or very low certainty.

Pelvic organ prolapse

A 2022 International Urogynecology Consultation review found 11 randomized trials in which PFMT reduced prolapse symptoms or improved stage by one in women with stage I to III prolapse. Nine of ten trials found no added effect from PFMT before and after prolapse surgery, no primary prevention trials were found, and long-term follow-up studies were few and inconsistent.

Pregnancy and postpartum

A 2020 Cochrane review of 46 trials with 10,832 women found that antenatal PFMT in continent women probably lowers the risk of reporting incontinence in late pregnancy (risk ratio 0.38; 6 trials, 624 women; moderate quality) and lowers it in the mid-postnatal period (risk ratio 0.71; 5 trials, 673 women; high quality). There was no evidence that antenatal PFMT treats existing incontinence.

A 2026 meta-analysis of 29 trials, all conducted in China, found that adding electrical stimulation and biofeedback to PFMT lowered stress incontinence incidence within 12 months postpartum (moderate certainty) but gave very low-certainty findings for prolapse.

Pelvic pain and men

In a trial of 81 women with bladder pain syndrome and pelvic floor tenderness, 59% responded to myofascial physical therapy versus 26% to global therapeutic massage on a global response scale. Pain, urgency and frequency ratings improved in both groups without a significant difference between them.

The 2024 radiofrequency comparison found pain reduced in both arms with no significant difference, but it had no inactive comparator. For men after prostatectomy, a review of 17 trials could not pool results, and a meta-analysis of five studies found no added benefit from preoperative training.

Limits of the evidence

In the 2018 Cochrane review, follow-up was generally under 12 months, many trials had moderate risk of bias, and only one trial studied mixed incontinence and one urgency incontinence alone. In the 2024 review, 44 trials had unclear or high selection bias risk. Searches for overactive pelvic floor and dyspareunia reviews in PubMed returned none, but other databases were not searched.

Reported adverse events

In the 2024 Cochrane review only nine of 63 trials collected adverse event data. In those, 66 of 1,083 women (6%) had an event, almost all linked to an intravaginal or intrarectal training device, and the events were vaginal discharge, spotting or discomfort.

The 2018 Cochrane review described adverse events as rare and minor in the two trials reporting any. In pregnancy, two participants in one study of 43 women withdrew because of pelvic floor pain. In the myofascial trial, pain was the most common adverse event at similar rates in both arms, with no serious events.

Suitability and care boundaries

The 2024 review excluded participants with neurological conditions and women who were pregnant or recently postpartum, so its findings do not apply to them. New, persistent or worsening leakage, bowel or bladder change, pelvic pain or a vaginal bulge warrants clinical assessment, and pelvic floor therapy should not delay or replace necessary care.

Training and access

No professional-body register, code of ethics or training standard for pelvic floor therapists was verified among the sources reviewed. The NHS describes continence services staffed by specialist nurses and physiotherapists. Titles and training requirements differ by country and are not stated in these sources.